Fluminorex
Tools
Actions
General
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Ffffrr (talk | contribs) at 15:26, 25 April 2022 (Importing Wikidata short description: "Chemical compound" (Shortdesc helper)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 15:26, 25 April 2022 by Ffffrr (talk | contribs) (Importing Wikidata short description: "Chemical compound" (Shortdesc helper))
Chemical compound
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H9F3N2O |
Molar mass | 230.190 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
(verify) |
Fluminorex is a centrally acting sympathomimetic which is related to other drugs such as aminorex and pemoline. It was developed as an appetite suppressant by McNeil Laboratories in the 1950s.[1]
See also
- 4'-Fluoro-4-methylaminorex
- 4-Methylaminorex
- Aminorex
- Clominorex
- Cyclazodone
- Fenozolone
- Pemoline
- Thozalinone
References
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Fluminorex" – news · newspapers · books · scholar · JSTOR (September 2009) (Learn how and when to remove this message) |
- ^ US Patent 3278382 - 2-amino-5-aryloxazoline compositions and methods of using same
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |